Abstract
The aim of this work is to obtain the bioactive compounds in hydroalcoholic extracts of hawthorn (Crataegus oxyacantha, Fam. Rosaceae), chokeberry (Aronia melanocarpa, Fam. Rosaceae), rosehip (Rosa canina, Fam. Roseaceae) and bilberry (Vaccinium myrtillus L., Fam. Ericaceae) by means of membrane separation process. Fruit extracts were processed by microfiltration at ambient temperature and the bioactive compounds were subsequently characterized. The microfiltration of plant extracts led to the concentration of biologically active compounds including polyphenols, procyanidins, flavanols, and their separation from lower molecular weight compounds (amino acids, monosaccharides etc.), passed into the microfiltration permeate solutions. To investigate the antioxidant activity of each plant extract, cupric ion reduction antioxidant capacity (CUPRAC) spectrophotometric methodology was employed.
Keywords: Microfiltration, hawthorn, bilberry, chokeberry, rosehip, bioactive compounds, antioxidant activity.
Current Bioactive Compounds
Title:The Bioactive Compounds Obtained from Hawthorn, Chokeberry, Rosehip and Bilberry by Microfiltration
Volume: 9 Issue: 2
Author(s): Mihaela Pascu (Neagu), Daniela - Elena Pascu, Gina Alina Traistaru, Andrei A. Bunaciu and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Microfiltration, hawthorn, bilberry, chokeberry, rosehip, bioactive compounds, antioxidant activity.
Abstract: The aim of this work is to obtain the bioactive compounds in hydroalcoholic extracts of hawthorn (Crataegus oxyacantha, Fam. Rosaceae), chokeberry (Aronia melanocarpa, Fam. Rosaceae), rosehip (Rosa canina, Fam. Roseaceae) and bilberry (Vaccinium myrtillus L., Fam. Ericaceae) by means of membrane separation process. Fruit extracts were processed by microfiltration at ambient temperature and the bioactive compounds were subsequently characterized. The microfiltration of plant extracts led to the concentration of biologically active compounds including polyphenols, procyanidins, flavanols, and their separation from lower molecular weight compounds (amino acids, monosaccharides etc.), passed into the microfiltration permeate solutions. To investigate the antioxidant activity of each plant extract, cupric ion reduction antioxidant capacity (CUPRAC) spectrophotometric methodology was employed.
Export Options
About this article
Cite this article as:
(Neagu) Pascu Mihaela, Pascu Daniela - Elena, Traistaru Alina Gina, Bunaciu A. Andrei and Aboul-Enein Y. Hassan, The Bioactive Compounds Obtained from Hawthorn, Chokeberry, Rosehip and Bilberry by Microfiltration, Current Bioactive Compounds 2013; 9 (2) . https://dx.doi.org/10.2174/22115528112019990008
DOI https://dx.doi.org/10.2174/22115528112019990008 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Ion Channels in Pulmonary Arterial Hypertension
Current Pharmaceutical Design Obesity-Induced Cerebral Hypoperfusion Derived from Endothelial Dysfunction: One of the Risk Factors for Alzheimer's Disease
Current Alzheimer Research Patents and Heart Valve Surgery - I: Mechanical Valves
Recent Patents on Cardiovascular Drug Discovery Anti-inflammatory Glycosylated Flavonoids as Therapeutic Agents for Treatment of Diabetes-Impaired Wounds
Current Topics in Medicinal Chemistry Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Targeting Adenosine Signaling to Treatment of Diabetic Nephropathy
Current Drug Targets Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Stem Cell Therapies
Recent Patents on Regenerative Medicine Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
Current Pharmaceutical Analysis Novelty in Treatment of Pulmonary Fibrosis: Pulmonary Hypertension Drugs and Others
Cardiovascular & Hematological Agents in Medicinal Chemistry Beta-Blockers (Carvedilol) in Children with Systemic Ventricle Systolic Dysfunction - Systematic Review and Meta-Analysis
Reviews on Recent Clinical Trials Meet Our Section Editor
Current Diabetes Reviews Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry A Review on the Risk of Myocardial Infarction Associated with the NSAID Diclofenac
Cardiovascular & Hematological Disorders-Drug Targets Cardiac Telocytes
Current Stem Cell Research & Therapy Pharmacological Therapy in Children with Nodal Reentry Tachycardia: When, How and How Long to Treat the Affected Patients
Current Pharmaceutical Design A Clinical Decision Support System for Assessing the Risk of Cardiovascular Diseases in Diabetic Hemodialysis Patients
Current Diabetes Reviews